Phenylmethimazole and a thiazole derivative of phenylmethimazole inhibit IL-6 expression by triple negative breast cancer cells-Reference-Cited by-同舟云学术

Phenylmethimazole and a thiazole derivative of phenylmethimazole inhibit IL-6 expression by triple negative breast cancer cells

Published:2017-05 Issue: Volume:803 Page:130-137
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Noori Mahboubeh S.,O’Brien John D.,Champa Zachary J.,Deosarkar Sudhir P.,Lanier Olivia L.,Qi Chunyan,Burdick Monica M.,Schwartz Frank L.,Bergmeier Stephen C.,McCall Kelly D.,Goetz Douglas J.

Funder

NIH

NSF

Publisher

Elsevier BV

Subject

Pharmacology

Reference34 articles.

1. Cancer stem cells, cancer-initiating cells and methods for their detection;Akbari-Birgani;Drug Discov. Today,2016

2. Simple modifications to methimazole that enhance its inhibitory effect on tumor necrosis factor-alpha-induced vascular cell adhesion molecule-1 expression by human endothelial cells;Alapati;Eur. J. Pharmacol.,2015

3. Interleukin-6 repression is associated with a distinctive chromatin structure of the gene;Armenante;Nucleic Acids Res.,1999

4. Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth;Barbie;J. Clin. Investig.,2014

5. HCELL is the major E- and L-selectin ligand expressed on LS174T colon carcinoma cells;Burdick;J. Biol. Chem.,2006

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: Toll-like receptor expression in transformed cells: role in tumor development and cancer therapies;Frontiers in Immunology;2024-08-22

2. Small molecule agents for triple negative breast cancer: Current status and future prospects;Translational Oncology;2024-03

3. Hetero Cyclic Compounds in the Treatment of Triple-Negative Breast Cancer;Current Cancer Therapy Reviews;2023-08

4. Toll‑like receptor 3 ligands for breast cancer therapies (Review);Molecular and Clinical Oncology;2023-06-22

5. Hormonal Regulation of the MHC Class I Gene in Thyroid Cells: Role of the Promoter “Tissue-Specific” Region;Frontiers in Endocrinology;2021-12-06